1. Home
  2. ZURA vs BRBI Comparison

ZURA vs BRBI Comparison

Compare ZURA & BRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zura Bio Limited

ZURA

Zura Bio Limited

N/A

Current Price

$6.95

Market Cap

435.0M

Sector

Health Care

ML Signal

N/A

BRBI

BRBI BR Partners S.A. ADSs

N/A

Current Price

$14.92

Market Cap

394.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ZURA
BRBI
Founded
2022
2009
Country
United States
Brazil
Employees
30
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
435.0M
394.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ZURA
BRBI
Price
$6.95
$14.92
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$11.78
N/A
AVG Volume (30 Days)
487.2K
1.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
5.33%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$33.39
Revenue Next Year
N/A
$17.24
P/E Ratio
N/A
$11.72
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$12.54
52 Week High
$7.19
$67.01

Technical Indicators

Market Signals
Indicator
ZURA
BRBI
Relative Strength Index (RSI) 60.40 52.36
Support Level $5.62 $12.85
Resistance Level N/A $14.97
Average True Range (ATR) 0.50 0.23
MACD 0.00 -0.05
Stochastic Oscillator 75.20 60.75

Price Performance

Historical Comparison
ZURA
BRBI

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About BRBI BRBI BR Partners S.A. ADSs

BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered.

Share on Social Networks: